Dr. Christopher Rogers and Dr. Mary Ambach from the San Diego Orthobiologics Medical Group are one of only 10 sites treating patients in a multi-center clinical trial for the treatment of knee osteoarthritis using a patient’s own fat-derived stem cells.  Personalized Stem Cells, Inc is sponsoring the FDA approved clinical trial, which is the FIRST EVER in the United States to study the use of a patient’s own fat-derived stem cells processed and tested in a centralized FDA inspected manufacturing lab.   In addition to treating knee osteoarthritis, the patient’s stem cells may be stored in this facility and potentially used for the treatment of other medical conditions in future approved clinical trials.

Information about the clinical trial can be found here.

Check for updates regarding the study and the recruitment process on our website, SDOMG.com


Pin It on Pinterest

Share This